Antileukemic activity of lysophosphatidic acid acyltransferase-β inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib
Paul La Rosée, Taiping Jia, Shadmer Demehri, Nicolai Härtel, Peter De Vries, Lynn Bonham, David Hollenback, Jack W. Singer, Junia V. Melo, Brian J. Druker, Michael W. Deininger
Dive into the research topics of 'Antileukemic activity of lysophosphatidic acid acyltransferase-β inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib'. Together they form a unique fingerprint.